Medicare and End-of-Life Care in California
This infographic provides a snapshot of Medicare and end-of-life care in California.
View the Latest: Federal Budget
Filter
-
-
What Might a Trump Administration Mean for Medicaid?
News ReleaseThis new fact sheet examines key questions around the potential changes President-elect Donald Trump and the next Congress may seek to make in Medicaid, a program that covers 73 million people nationally.
-
Key Medicaid Questions Post-Election
Fact SheetThis fact sheet provides insight into how a repeal of the Affordable Care Act (ACA) and changes in the financing structure would affect Medicaid, including the Medicaid expansion, and how a Trump administration could change Medicaid through administrative actions.
-
Health Affairs Blog: The Cost Of A Cure: Revisiting Medicare Part D And Hepatitis C Drugs
PerspectiveThis blog post revisits an earlier analysis of the drug Sovaldi (sofosbuvir) using new data released by the Centers for Medicare and Medicaid Services, and considers both the ongoing impact of hepatitis C drugs for Medicare Part D and the broader implications for Medicare of new high-priced drugs entering the market.
-
Medicare and End-of-Life Care
FeatureMedicare and End-of-Life Care_JAMA 110116 Download View the JAMA Infographic…
-
Visualizing Health Policy: Medicare and End-of-Life Care
OtherThis Visualizing Health Policy infographic, produced in partnership with the Journal of the American Medical Association (JAMA), provides a snapshot of Medicare and end-of-life care.
-
Visualizing Health Policy: Medicare and End-of-Life Care
News ReleaseThis Visualizing Health Policy infographic, produced in partnership with the Journal of the American Medical Association (JAMA), provides a snapshot of Medicare and end-of-life care
-
The Status of Funding for Zika: The President’s Request, Congressional Proposals, & Final Funding
Issue BriefThis issue brief provides a landscape of the status of U.S. funding for Zika, a mosquito-transmitted infection that in pregnant women can cause microcephaly as well as other serious birth defects. The brief compares the Congressionally approved Zika funding levels, which provides $1.1 billion to the Zika response, to the President’s February 22nd request, the House and Senate bills that passed each chamber in May, and a Conference Agreement that had been approved by the House in June, but was blocked in the Senate and opposed by the Administration.
-
Web Event: Rx Drugs and the U.S. Health System – A Conversation about Election-Cycle Proposals for Lowering Costs
Event Date:EventOn Wednesday, October 5, from noon to 1 p.m. ET, the Kaiser Family Foundation will host a web conversation to discuss proposals for controlling prescription drug costs, examine pros and cons of the ideas, and assess the likelihood that the plans will be enacted.
-
Medicare Part D Spending on the EpiPen Increased More than 1000 Percent from 2007 to 2014
News ReleaseAs policymakers in Washington scrutinize the rising cost of the EpiPen auto-injector, a new analysis from the Kaiser Family Foundation shows that Medicare Part D spending for the potentially life-saving device increased by more than 1000 percent between 2007, the year after the Part D drug benefit took effect, and 2014, the most recent year…